Pulmonary Vasculature Responsiveness to Phosphodiesterase-5A Inhibition in Heart Failure With Reduced Ejection Fraction: Possible Role of Plasma Potassium.

Monzo, Luca; Reichenbach, Adrian; Al-Hiti, Hikmet; Jurcova, Ivana; Huskova, Zuzana; Kautzner, Josef; Melenovsky, Vojtech

Monzo, Luca; Reichenbach, Adrian; Al-Hiti, Hikmet; Jurcova, Ivana; Huskova, Zuzana; Kautzner, Josef; Melenovsky, Vojtech.

Afiliação

Monzo L; Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia.
Reichenbach A; Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University, Rome, Italy.
Al-Hiti H; Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia.
Jurcova I; Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia.
Huskova Z; Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia.
Kautzner J; Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia.
Melenovsky V; Institute for Clinical and Experimental Medicine (IKEM), Prague, Czechia.

Front Cardiovasc Med ; 9: 883911, 2022.

Article em En | MEDLINE | ID: mdl-35722098

Palavras-chave

heart failure; phospodiesterase inhibitors; potassium; pulmonary hypertension; pulmonary vascular resistance

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google